Digoxin 01
Digoxin
Product Images NDC 57664-437
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 57664-437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display-0.125 (Digoxin 02)
This is a medication called Digoxin in the form of tablets, with each tablet containing 0.125mg of the substance. The recommended dosage information is provided in the package outsert. The tablets should be dispensed in a light-resistant container as defined in the USP and kept out of reach of children. Storage should be at a controlled room temperature, protected from light and in a dry place. The tablets are produced by Sun Pharmaceutical Industries Ltd. and distributed by Sum Pharmaceutical Industries, located in Cranbury, New Jersey. The NDC number is 57664-437-88, and each bottle contains 100 tablets. The text also includes manufacturing and expiration dates, a lot number, and a GTIN and SN number.*
Principal Display-0.25 (Digoxin 03)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
